JP2017214410A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017214410A5 JP2017214410A5 JP2017135811A JP2017135811A JP2017214410A5 JP 2017214410 A5 JP2017214410 A5 JP 2017214410A5 JP 2017135811 A JP2017135811 A JP 2017135811A JP 2017135811 A JP2017135811 A JP 2017135811A JP 2017214410 A5 JP2017214410 A5 JP 2017214410A5
- Authority
- JP
- Japan
- Prior art keywords
- thiophen
- biphenyl
- ethoxy
- carbonyl
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BMBXBJUGRINIDQ-MRXNPFEDSA-N 1-[4-[4-[5-chloro-3-[[(1r)-1-thiophen-2-ylethoxy]carbonylamino]thiophen-2-yl]-2-methoxyphenyl]phenyl]cyclopropane-1-carboxylic acid Chemical compound COC1=CC(C2=C(C=C(Cl)S2)NC(=O)O[C@H](C)C=2SC=CC=2)=CC=C1C(C=C1)=CC=C1C1(C(O)=O)CC1 BMBXBJUGRINIDQ-MRXNPFEDSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012286425 | 2012-12-28 | ||
| JP2012286425 | 2012-12-28 | ||
| JP2013097171 | 2013-05-02 | ||
| JP2013097171 | 2013-05-02 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014554626A Division JP6176258B2 (ja) | 2012-12-28 | 2013-12-27 | ハロゲン置換へテロ環化合物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018188246A Division JP6569792B2 (ja) | 2012-12-28 | 2018-10-03 | ハロゲン置換へテロ環化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017214410A JP2017214410A (ja) | 2017-12-07 |
| JP2017214410A5 true JP2017214410A5 (enExample) | 2018-02-08 |
| JP6414286B2 JP6414286B2 (ja) | 2018-10-31 |
Family
ID=51021433
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014554626A Active JP6176258B2 (ja) | 2012-12-28 | 2013-12-27 | ハロゲン置換へテロ環化合物 |
| JP2017135811A Active JP6414286B2 (ja) | 2012-12-28 | 2017-07-11 | ハロゲン置換へテロ環化合物 |
| JP2018188246A Active JP6569792B2 (ja) | 2012-12-28 | 2018-10-03 | ハロゲン置換へテロ環化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014554626A Active JP6176258B2 (ja) | 2012-12-28 | 2013-12-27 | ハロゲン置換へテロ環化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018188246A Active JP6569792B2 (ja) | 2012-12-28 | 2018-10-03 | ハロゲン置換へテロ環化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10000463B2 (enExample) |
| EP (2) | EP2940013B1 (enExample) |
| JP (3) | JP6176258B2 (enExample) |
| KR (1) | KR102189166B1 (enExample) |
| CN (2) | CN107698555B (enExample) |
| AU (1) | AU2013366898B2 (enExample) |
| BR (1) | BR112015015275B1 (enExample) |
| CA (1) | CA2896701C (enExample) |
| DK (2) | DK2940013T3 (enExample) |
| ES (2) | ES2667798T3 (enExample) |
| MX (1) | MX369801B (enExample) |
| RU (2) | RU2756506C2 (enExample) |
| WO (1) | WO2014104372A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107698555B (zh) * | 2012-12-28 | 2020-05-05 | 宇部兴产株式会社 | 卤素取代杂环化合物 |
| CN105142635B (zh) | 2013-03-15 | 2021-07-27 | 艾匹根生物技术有限公司 | 有用于治疗疾病的杂环化合物 |
| JP2014231508A (ja) * | 2013-05-02 | 2014-12-11 | 宇部興産株式会社 | ハロゲン置換へテロ環化合物 |
| CN106458964B (zh) * | 2014-06-27 | 2019-11-22 | 宇部兴产株式会社 | 卤素取代杂环化合物的盐 |
| KR20180082564A (ko) * | 2015-11-20 | 2018-07-18 | 우베 고산 가부시키가이샤 | Nash의 치료 또는 예방을 위한 의약 조성물 |
| KR20220039718A (ko) * | 2019-07-30 | 2022-03-29 | 다이쇼 세이야꾸 가부시끼가이샤 | Lpa1 수용체를 길항하는 우레아 화합물 |
| CN114728168B (zh) | 2019-11-15 | 2024-04-09 | 吉利德科学公司 | 三唑氨基甲酸酯吡啶基磺酰胺作为lpa受体拮抗剂及其用途 |
| TWI843503B (zh) | 2020-06-03 | 2024-05-21 | 美商基利科學股份有限公司 | Lpa受體拮抗劑及其用途 |
| EP4161936A1 (en) | 2020-06-03 | 2023-04-12 | Gilead Sciences, Inc. | Lpa receptor antagonists and uses thereof |
| CN111909170B (zh) * | 2020-09-11 | 2022-08-12 | 吉林奥来德光电材料股份有限公司 | 一种有机电致发光化合物、其制备方法以及包含该有机电致发光化合物的有机电致发光器件 |
| EP4337641A1 (en) | 2021-05-11 | 2024-03-20 | Gilead Sciences, Inc. | Lpa receptor antagonists and uses thereof |
| JP7691522B2 (ja) | 2021-05-13 | 2025-06-11 | ギリアード サイエンシーズ， インコーポレイテッド | Ｌｐａ受容体アンタゴニスト及びそれらの使用 |
| EP4444707A1 (en) | 2021-12-08 | 2024-10-16 | Gilead Sciences, Inc. | Lpa receptor antagonists and uses thereof |
| CA3222642A1 (en) | 2022-12-12 | 2024-06-12 | Bmic Llc | Downstream uses for briquettes and other forms of powder from asphalt shingle waste |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001060819A1 (en) * | 2000-02-18 | 2001-08-23 | Kirin Beer Kabushiki Kaisha | Novel isoxazole and thiazole compounds and use thereof as drugs |
| DE60234318D1 (de) | 2001-02-08 | 2009-12-24 | Ono Pharmaceutical Co | Mittel zur behandlung von harnwegserkrankungen, umfassend mittel zur kontrolle des lpa-rezeptors |
| WO2005012269A1 (ja) * | 2003-08-05 | 2005-02-10 | Ajinomoto Co., Inc. | 新規アゾール化合物 |
| EA020742B1 (ru) | 2008-09-29 | 2015-01-30 | Эли Лилли Энд Компани | Селективный модулятор рецепторов эстрогена |
| GB2466121B (en) * | 2008-12-15 | 2010-12-08 | Amira Pharmaceuticals Inc | Antagonists of lysophosphatidic acid receptors |
| GB2470833B (en) | 2009-06-03 | 2011-06-01 | Amira Pharmaceuticals Inc | Polycyclic antagonists of lysophosphatidic acid receptors |
| EP2462128B1 (en) | 2009-08-04 | 2016-09-21 | Amira Pharmaceuticals, Inc. | Compounds as lysophosphatidic acid receptor antagonists |
| GB2474120B (en) | 2009-10-01 | 2011-12-21 | Amira Pharmaceuticals Inc | Compounds as Lysophosphatidic acid receptor antagonists |
| GB2474748B (en) | 2009-10-01 | 2011-10-12 | Amira Pharmaceuticals Inc | Polycyclic compounds as lysophosphatidic acid receptor antagonists |
| WO2011091167A2 (en) | 2010-01-22 | 2011-07-28 | The General Hospital Corporation | Lysophosphatidic acid receptor targeting for scleroderma and other fibrotic diseases |
| WO2011159632A1 (en) | 2010-06-15 | 2011-12-22 | Amira Pharmaceuticals, Inc. | Lysophosphatidic acid receptor antagonists for the treatment of conditions or diseases of the eye |
| WO2011159633A1 (en) | 2010-06-15 | 2011-12-22 | Amira Pharmaceuticals, Inc. | Inhalable formulations of lysophosphatdic acid receptor antagonists |
| WO2011159635A1 (en) | 2010-06-15 | 2011-12-22 | Amira Pharmaceuticals, Inc. | Lysophosphatidic acid receptor antagonist for the treatment of dermal conditions |
| PH12013501136A1 (en) | 2010-12-07 | 2013-07-08 | Amira Pharmaceuticals Inc | Lysophosphatidic acid receptor antagonists and uses thereof |
| CN107721940A (zh) | 2010-12-07 | 2018-02-23 | 阿米拉制药公司 | 多环lpa1拮抗剂及其使用 |
| WO2012138797A1 (en) * | 2011-04-05 | 2012-10-11 | Amira Pharmaceuticals, Inc. | 3- or 5 - bi phenyl - 4 - ylisoxazole - based compounds useful for the treatment of fibrosis, pain, cancer and respiratory, allergic, nervous system or cardiovascular disorders |
| WO2012138648A1 (en) * | 2011-04-06 | 2012-10-11 | Irm Llc | Compositions and methods for modulating lpa receptors |
| CA2844982A1 (en) | 2011-08-15 | 2013-02-21 | Intermune, Inc. | Lysophosphatidic acid receptor antagonists |
| CN107698555B (zh) * | 2012-12-28 | 2020-05-05 | 宇部兴产株式会社 | 卤素取代杂环化合物 |
-
2013
- 2013-12-27 CN CN201710949188.8A patent/CN107698555B/zh active Active
- 2013-12-27 ES ES13868493.1T patent/ES2667798T3/es active Active
- 2013-12-27 EP EP13868493.1A patent/EP2940013B1/en active Active
- 2013-12-27 RU RU2018109925A patent/RU2756506C2/ru active
- 2013-12-27 MX MX2015008479A patent/MX369801B/es active IP Right Grant
- 2013-12-27 BR BR112015015275-9A patent/BR112015015275B1/pt active IP Right Grant
- 2013-12-27 KR KR1020157019230A patent/KR102189166B1/ko active Active
- 2013-12-27 WO PCT/JP2013/085277 patent/WO2014104372A1/ja not_active Ceased
- 2013-12-27 EP EP18157384.1A patent/EP3360869B1/en active Active
- 2013-12-27 CN CN201380068911.1A patent/CN104884447B/zh active Active
- 2013-12-27 JP JP2014554626A patent/JP6176258B2/ja active Active
- 2013-12-27 ES ES18157384T patent/ES2825031T3/es active Active
- 2013-12-27 AU AU2013366898A patent/AU2013366898B2/en active Active
- 2013-12-27 CA CA2896701A patent/CA2896701C/en active Active
- 2013-12-27 DK DK13868493.1T patent/DK2940013T3/en active
- 2013-12-27 DK DK18157384.1T patent/DK3360869T3/da active
- 2013-12-27 RU RU2015131139A patent/RU2649398C2/ru active
-
2015
- 2015-06-26 US US14/752,623 patent/US10000463B2/en active Active
-
2017
- 2017-07-11 JP JP2017135811A patent/JP6414286B2/ja active Active
-
2018
- 2018-05-08 US US15/974,494 patent/US10597375B2/en active Active
- 2018-10-03 JP JP2018188246A patent/JP6569792B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017214410A5 (enExample) | ||
| JP2016153424A5 (enExample) | ||
| JP2013539454A5 (enExample) | ||
| JP2018024670A5 (enExample) | ||
| JP2009004351A5 (enExample) | ||
| JP2009530282A5 (enExample) | ||
| JP2010501534A5 (enExample) | ||
| EA201170227A1 (ru) | Имидазолкарбоксамиды | |
| EP2753605A4 (en) | COMPOSITIONS, METHODS AND SYSTEMS FOR SYNTHESIS AND USE OF CONTRASTING AGENTS | |
| CL2021000373S1 (es) | Contenedor. (divisional solicitud 202000878) | |
| JP2018116258A5 (enExample) | ||
| NO20082837L (no) | Isotopmerkede benzotiazolforbindelser som avbildningsmidler for amyloidogene proteiner | |
| JP2010070692A5 (enExample) | ||
| DK3402784T3 (da) | 3-((hetero-)aryl)-alkyl-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater | |
| JP2010241791A5 (enExample) | ||
| CY1115577T1 (el) | Μεθοδος για την παρασκευη εναντιομερικως καθαρων αμινων | |
| DK3402781T5 (da) | 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4,5]-decan-derivater | |
| CL2021000375S1 (es) | Contenedor. (divisional solicitud 202000650) | |
| JP2010243737A5 (enExample) | ||
| JP2017042232A5 (enExample) | ||
| JP2018128902A5 (enExample) | ||
| DE602006018910D1 (de) | 1-(imidazolin-2-yl)amino-1,2-diphenylethan-verbindungen zur bekämpfung von tierpestkrankheiten | |
| JP2010217838A5 (enExample) | ||
| JP2016175963A5 (enExample) | ||
| JP2018045476A5 (enExample) |